Page 31 - Small Cap U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
VRNA Verona Pharma	US$42.02	1.4%	139.3%	US$3.4b	US$47.29	PS611.4x	E72.8%	n/a
RYTM Rhythm Pharmaceuticals	US$56.12	1.6%	21.1%	US$3.4b	US$72.82	PS30.6x	E69.0%	n/a
CRSP CRISPR Therapeutics	US$40.72	-7.0%	-36.0%	US$3.4b	US$81.75	PS17.1x	E37.2%	n/a
PTCT PTC Therapeutics	US$46.24	-0.3%	67.5%	US$3.5b	US$58.71	PS4x	E63.1%	n/a
PRGO Perrigo	US$25.75	-6.2%	-18.8%	US$3.5b	US$35.80	PB0.8x	E63.8%	4.3%
BHVN Biohaven	US$36.26	-5.7%	-9.5%	US$3.6b	US$65.29	PB11.6x	E20.9%	n/a
ALVO Alvotech	US$11.91	0.9%	6.1%	US$3.7b	US$17.40	PS9.1x	E99.0%	n/a
RNA Avidity Biosciences	US$31.82	-2.1%	245.3%	US$3.7b	US$68.27	PS375.3x	E27.4%	n/a
OGN Organon	US$14.58	-4.7%	4.8%	US$3.7b	US$22.25	PE2.9x	E-8.3%	7.7%
CBAY CymaBay Therapeutics	US$32.48	0.03%	262.9%	US$3.7b	US$32.50	PS120x	E54.8%	n/a
RYZB RayzeBio	US$62.49	0%	n/a	US$3.7b	US$53.33	PB6.5x	E2.0%	n/a
SHC Sotera Health	US$13.24	0.7%	-20.4%	US$3.8b	US$16.19	PE53.2x	E41.0%	n/a
IMVT Immunovant	US$25.86	-1.6%	-37.7%	US$3.8b	US$48.79	PB8.5x	E7.8%	n/a
TPTX Turning Point Therapeutics	US$76.01	1.3%	18.9%	US$3.8b	US$76.00	PS3776x	E24.7%	n/a
PBH Prestige Consumer Healthcare	US$78.72	-4.3%	27.1%	US$3.9b	US$85.29	PE18.9x	E5.3%	n/a
SRRK Scholar Rock Holding	US$44.78	6.7%	138.8%	US$3.9b	US$46.38	PB52.9x	E53.4%	n/a
RARE Ultragenyx Pharmaceutical	US$44.22	-3.4%	-6.9%	US$4.0b	US$92.95	PS7.8x	E51.9%	n/a
ACLX Arcellx	US$75.54	-9.9%	40.3%	US$4.1b	US$116.38	PS26.2x	E-3.2%	n/a
APLS Apellis Pharmaceuticals	US$33.21	0.06%	-42.5%	US$4.1b	US$45.75	PS5.8x	E72.3%	n/a
ADMA ADMA Biologics	US$17.40	-6.4%	310.4%	US$4.2b	US$24.25	PE60.4x	E30.5%	n/a
AXSM Axsome Therapeutics	US$90.73	0.7%	18.1%	US$4.3b	US$130.47	PS13x	E72.5%	n/a
TGTX TG Therapeutics	US$32.20	0.6%	89.4%	US$4.4b	US$40.75	PS17.5x	E57.0%	n/a
ALPN Alpine Immune Sciences	US$64.97	0.03%	518.2%	US$4.5b	US$62.00	PS78.9x	E-9.9%	n/a
SYNH Syneos Health	US$42.98	0.6%	-8.8%	US$4.5b	US$42.63	PE62.6x	E33.7%	n/a